Methylprednisolone Sodium Succinate

Product NDC
71329-304
11-digit product format
713290304
Labeler code
71329
Product ID
71329-304_5c22bf7e-4275-40f4-8502-fd9d34801557
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Methylprednisolone
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
GeneYork Pharmaceuticals Group LLC
Application
ANDA212396
Marketing category
ANDA
Marketing start
2021-04-20
Marketing end
0000-00-00
Substance
METHYLPREDNISOLONE SODIUM SUCCINATE
Active strength
1 g/16mL
Pharmacologic classes
Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71329-304-012023-01-30C16284748780-1f386c649-b168-0266-e053-dadaa90a7c1a23b17612-b122-4c89-80a7-5f3ca57fad7f

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71329-304METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENEYORK PHARMACEUTICALS GROUP LLC]3Legacy NDC20210428_23b17612-b122-4c89-80a7-5f3ca57fad7f.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71329-304-017132903040116 mL in 1 VIAL (71329-304-01) 16 ml2021-04-200000-00-00NoNoCurrent